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Background: In 2009, the NHS evidence adoption center and National Institute for Health and Care Excellence
(NICE) published a review of the use of endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs).
They recommended the development of a risk-assessment tool to help identify AAA patients with greater or lesser
risk of operative mortality and to contribute to mortality prediction.
A low anaerobic threshold (AT), which is a reliable, objective measure of pre-operative cardiorespiratory fitness, as
determined by pre-operative cardiopulmonary exercise testing (CPET) is associated with poor surgical outcomes for
major abdominal surgery. We aimed to assess the impact of a CPET-based risk-stratification strategy upon
perioperative mortality, length of stay and non-operative costs for elective (open and endovascular) infra-renal AAA
patients.
Methods: A retrospective cohort study was undertaken. Pre-operative CPET-based selection for elective surgical
intervention was introduced in 2007. An anonymized cohort of 230 consecutive infra-renal AAA patients (2007 to
2011) was studied. A historical control group of 128 consecutive infra-renal AAA patients (2003 to 2007) was
identified for comparison.
Comparative analysis of demographic and outcome data for CPET-pass (AT ≥ 11 ml/kg/min), CPET-fail (AT < 11 ml/
kg/min) and CPET-submaximal (no AT generated) subgroups with control subjects was performed. Primary
outcomes included 30-day mortality, survival and length of stay (LOS); secondary outcomes were non-operative
inpatient costs.
Results: Of 230 subjects, 188 underwent CPET: CPET-pass n = 131, CPET-fail n = 35 and CPET-submaximal n = 22.
When compared to the controls, CPET-pass patients exhibited reduced median total LOS (10 vs 13 days for open
surgery, n = 74, P < 0.01 and 4 vs 6 days for EVAR, n = 29, P < 0.05), intensive therapy unit requirement (3 vs 4 days
for open repair only, P < 0.001), non-operative costs (£5,387 vs £9,634 for open repair, P < 0.001) and perioperative
mortality (2.7% vs 12.6% (odds ratio: 0.19) for open repair only, P < 0.05). CPET-stratified (open/endovascular)
patients exhibited a mid-term survival benefit (P < 0.05).
Conclusion: In this retrospective cohort study, a pre-operative AT > 11 ml/kg/min was associated with reduced
perioperative mortality (open cases only), LOS, survival and inpatient costs (open and endovascular repair) for
elective infra-renal AAA surgery.
Keywords: AAA, Abdominal aortic aneurysm, CPET, Cardiopulmonary exercise test, Clinical outcomes* Correspondence: drgoodyear@hotmail.com
1University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge
Road, Coventry CV2 2DX, UK
Full list of author information is available at the end of the article
© 2013 Goodyear et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Goodyear et al. Perioperative Medicine 2013, 2:10 Page 2 of 13
http://www.perioperativemedicinejournal.com/content/2/1/10Background
It is more important to know what sort of person has a
disease than to know what sort of disease a person has
(Hippocrates, 460 to 370 BC).
Open abdominal aortic aneurysm (AAA) surgery
places substantial metabolic demands upon patients dur-
ing the perioperative period. These result from increased
energy requirements necessary for wound healing [1],
hemostasis, ventilation, significant intra-operative hemo-
dynamic [2,3] and acid/base fluctuations in addition to
the catecholamine stress response to surgery [4-6]. Fail-
ure of the cardiorespiratory system to meet these in-
creased metabolic requirements of patients undergoing
major abdominal surgery may lead to avoidable cardiore-
spiratory morbidity and mortality [7-10]. Aortic surgery
is associated with a high (≥5%) combined incidence of
cardiac death and non-fatal myocardial infarction [11].
An individual’s functional status has been shown to be
reliably predictive of perioperative and long-term cardiac
events following non-cardiac surgery [11], which can be
derived from an assessment of their ability to perform
activities of daily living [12,13]. Functional capacity (a
numeric measure of functional status) can be expressed
in metabolic equivalent (MET) levels; the oxygen con-
sumption (VO2) of a 70-kg, 40-year-old man in a resting
state is 3.5 ml/kg/min or 1 MET [11]. The American
College of Cardiology and American Heart Association
(ACC/AHA) guidelines for perioperative assessment
states that patients able to demonstrate a functional cap-
acity of 4 METS may safely proceed to surgery without
further cardiac assessment [14]. This equates to the abi-
lity to climb a flight of stairs or run a short distance.
However, subjective assessment of functional status by
clinicians for patients undergoing AAA repair, can be
easily confounded and lacks prognostic accuracy [15-17],
identifying a potential role for objective testing.
Static pre-operative tests of cardiac function, such as
resting left ventricular ejection fraction, correlate poorly
with cardiorespiratory (physical) fitness [18,19], whilst dy-
namic tests such as dobutamine stress echocardiography
and stress electrocardiogram (ECG) testing do not meas-
ure respiratory function and global oxygen delivery simul-
taneously. Cardiopulmonary exercise testing (CPET)
allows the objective quantification of the level at which
end-organ oxygen demand exceeds delivery [20] (the func-
tional reserve) and may be safely performed in high-risk
populations [7,15,21]. The transition point at which the
production of CO2 exceeds VO2 is known as the anaerobic
threshold (AT) and can be determined by gaseous ex-
change measurement during CPET [20]. More simply, the
AT is the work rate at which an individual’s cardiorespira-
tory system fails to deliver sufficient oxygen to maintainaerobic respiration, mandating usage of an anaerobic sub-
strate. AT is recognized as a reliable measure of pre-
operative fitness in AAA patient populations [22].
Older et al. demonstrated that a critical AT ≥
11 ml/kg/min for elderly subjects was associated with 0.8%
perioperative mortality rate in major abdominal surgery,
compared to 18% in individuals below this level [23]. In a
further study, the same center identified a less intensive
perioperative care requirement and reduced cardiovascular
and all-cause mortality for elderly (major surgical) patients
with AT ≥ 11, when compared to individuals below this
threshold [24]. Additional work has shown anaerobic
threshold >11 to be associated with fewer short-term
complications and hence a shorter length of inpatient stay
(LOS) following major abdominal surgery [25]. More
contemporary evidence highlights other variables obtained
during CPET to be at least as valuable (as AT) in
predicting short- and mid-term outcomes in elective AAA
surgery [7,26]. This is supported by a recent finding that
AT < 10.2 ml/kg/min and peak oxygen consumption
(VO2peak) < 15 ml/kg/min were associated with increased
30- and 90-day mortality following AAA surgery [27].
The aim of elective surgery for AAA is to prolong the
survival of patients. However, there is an increasing
awareness that many of these individuals have significant
and potentially life-threatening cardiorespiratory co-
morbidities [26]. Proactive screening for AAA reduces
the prevalence of aneurysm-related mortality [28] and
surgical intervention when the AAA ≥ 5.5 cm anterior-
posterior (AP) diameter is appropriate [29] in units that
have low perioperative complication rates. Large multi-
center trials such as EVAR-1 have published 30-day
mortality rates of 5.3% for open AAA repair [30]. How-
ever, the Vascular Society of Great Britain and Ireland’s
(VSGBI) quality improvement framework (QIF) target of
3.5% by 2013 suggests that this could be improved fur-
ther [31].
Pre-operative CPET was introduced for elective aneu-
rysm surgery at University Hospitals Coventry and
Warwickshire (UHCW) NHS Trust in 2007 in response to
a 30-day mortality rate of 12.6% for open elective surgery,
determined by internal audit and following an invited
review by the VSGBI. These data reflected the hospitals’
all-comers policy to elective aneurysm surgery, offering
operative repair to many individuals of equivocal cardio-
vascular health, who may have been declined intervention
in vascular units with more stringent perioperative selec-
tion. The observed mortality rate for unselected patients
prior to 2007 is comparable with the findings of Carlisle
and Swart (30-day mortality rate: 9%) [26], who studied
infra-renal AAA outcomes during a similar era. Whilst
12.6% 30-day mortality for unstratified (pre-CPET era)
open AAA surgery appears unacceptably high at first
glance, there is a significant moral dilemma to be ad-
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ity rate for ruptured AAA, generally accepted as 90% [32].
Nevertheless, these mortality data fell beyond the es-
tablished range quoted in the literature [33] and a trust-
wide guideline of pre-operative CPET-stratification-based
selection (for all elective AAA patients) was introduced, to
facilitate ongoing AAA intervention at the established
diameter of 5.5 cm, on a risk-benefit basis. Conservative
management was offered to individuals considered to be
at high risk of perioperative mortality following stratifica-
tion, based upon an extrapolation of the 2007 Carlisle and
Swart data [26].
This study aimed to assess the outcomes of pre-operative
CPET-stratification on the duration of postoperative in-
patient stay, intensive therapy unit (ITU) usage, end-organ
support, 30-day mortality rates and longer-term survival
following elective open and endovascular infra-renal AAA
repair.
Methods
This study is a retrospective, anonymized, single-center,
cohort study performed at UHCW NHS Trust, a cen-
tralized vascular unit serving a population of 950,000. A
review of the study proposal was undertaken by the
trust’s Research and Development department; ethical
approval was deemed unnecessary, based upon National
Research Ethics Service guidance [34].
From November 2007, all patients considered for elective
AAA repair (AAA ≥ 5.5 cm) surgery were recommended
pre-operative CPET. An evidence-based minimum anaer-
obic threshold of 11.0 ml/kg/min was selected to identify
individuals with adequate cardiopulmonary reserves who
would be able to tolerate general anesthesia and open ab-
dominal surgery, with acceptable perioperative mortality
rates (the CPET-pass subgroup). These individuals were of-
fered the option of endovascular aneurysm repair (EVAR),
if anatomically applicable, or open AAA repair. Individuals
attaining an AT < 11 ml/kg/min (the CPET-fail subgroup)
were counseled regarding conservative management if
EVAR (a less cardiovascularly challenging procedure) was
not anatomically feasible. CPET-fail patients with unfavo-
rable anatomy for infra-renal EVAR who requested open
repair (rather than expectant management), were permit-
ted to proceed following careful discussion and documen-
tation of the perceived increased mortality risk. Individuals
who were unable to demonstrate AT during CPET due to
mechanical co-morbidities, suboptimal effort, suboptimal
compliance with the investigation or ECG changes at min-
imal exertion (the CPET-submaximal subgroup) were
managed as per the CPET-fail subgroup.
Data collection and analysis
The data for 230 consecutive infra-renal AAA (≥5.5 cm
AP diameter) patients considered for elective surgerybetween November 2007 and July 2011 (the CPET era)
were studied. A control group of 128 consecutive indi-
viduals who underwent open or endovascular (infra-
renal) AAA repair between January 2003 and October
2007 (the pre-CPET era) were identified for comparison.
Patients diagnosed with thoracoabdominal or supra-
renal aneurysms were excluded from the data collection,
in addition to individuals who had undergone repairs of
ruptured or urgent (symptomatic, non-ruptured) AAA.
Individuals were identified (with permission) by the De-
partment of Clinical Coding using KMR1 diagnoses and
procedures. To ensure completeness of data, results were
cross-referenced with (computerized and written) operat-
ing theatre registries, the Dr Foster national outcomes
database and the results of an internal audit of mortality/
morbidity for elective AAA patients. Cardiopulmonary ex-
ercise testing data for CPET-era patients were collected
(with full permission of the Department of Respiratory
Physiology) from the UHCW CPET database.
Demographic and outcome data were identified by a
systematic review of the hospitals’ Clinical Results
Reporting System (CRRS) and the patient case notes.
Data loss was minimized by cross-referencing, using
anonymized patient identification (PID) numbers, with
the ITU patient digital registry and the CPET database.
Information relating to length of ITU stay and the num-
ber of end organs supported was obtained from the ITU
patient digital registry. Mortality data were sourced (with
permission) from CRRS, the hospitals’ Bereavement
Services Department and by liaison with primary care
providers. Survival was calculated from the date of inter-
vention until death or censorship, in days. For indivi-
duals managed conservatively (CPET era), survival was
calculated from the date of CPET until death or censor-
ship. Survival could be observed for up to eight years in
the control cohort and a maximum of four years for the
CPET-era cohort, within the constraints of this study
and this is regarded as mid-term survival. Tariffs for ITU
and ward stays were obtained from the Department of
Health Report 2010/2011 for UHCW via the Finance
Section of the Information Services department. ITU
cost data were calculated on an individual basis. A vari-
able tariff applied, based upon the total number of end
organs postoperatively supported (Table 1) multiplied by
the duration of ITU stay. Ward costs were calculated by
multiplication of a standard tariff (Table 1) by duration
of ward stay. Financial analysis did not consider the
costs of staff, equipment and consumables, which are es-
sentially constant throughout NHS organizations offe-
ring similar interventions.
Surgical technique
All elective infra-renal AAA repairs were discussed and
planned within a multidisciplinary team. Open aneurysm
Table 1 Ward-based and critical care unit costs per 24 h
stay
Location Discriminator Cost per day (£)
CPET One-off tariff 150
Surgical ward Influenceable costs 110
Fully absorbed costs 250
ITU 0 organs supported 260
1 organ supported 769
2 organs supported 1106
3 organs supported 1386
4 organs supported 1511
5 organs supported 1568
6 organs supported 1638
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geon, or a consultant-supervised higher surgical trainee,
using a transperitoneal inlay repair with knitted Dacron
graft prostheses. Endovascular aneurysm repairs were
planned and performed by a consultant vascular surgeon
and consultant interventional radiologist. The EVAR
devices used were the Cook Zenith® (Cook, Brisbane,
Australia) endovascular system, Medtronic Endurant®
(Medtronic, Minneapolis, MN, USA) and Lombard
Aorfix™ (Lombard Medical, Oxfordshire, UK).
Cardiopulmonary exercise testing
Prior to testing, the patient’s body mass index (BMI) was
determined by measurement of height and weight. Res-
ting spirometry was performed to measure forced ex-
piratory volume per second (FEV1) and forced vital
capacity (FVC), from which FEV1/FVC ratios were cal-
culated. Predicted FEV1 and FVC values were derived as
a function of age, height, ethnicity and gender (calcu-
lated by the CPET software – see below). FEV1 data were
used to assess an individual’s maximum predicted venti-
lation. The patient’s weight and predicted maximum
oxygen uptake (VO2max) were used to calculate the
individually required work rate on the cycle ergometer.
Patients were subsequently attached to a 12-lead ECG
and a form-fitting face-mask connected to a metabolic
cart with protocol specific software (Viasprint Ergometer
and MasterScreen CPX software v5.21.0.60, CareFusion
Corporation, CA, USA). Patients were initially made to
pedal for an unloaded phase (work rate 0 W at 50 rpm
for 3 min) followed by a ramped phase requiring a con-
stant 70 rpm against increasing resistance until they
reached their peak oxygen uptake (VO2peak). The test
could be stopped at any point during the test protocol
due to patient fatigue, presence of ischemic ECG
changes, chest pain or if the maximum heart rate was
achieved. The AT was derived using the V-slope method
as described by Beaver et al. [35].Statistical analysis
All data were tabulated using a Microsoft Excel® spread-
sheet (Microsoft, CA, USA) and statistical analyses
performed using Graphpad Prism4® (Graphpad, La Jolla,
CA, USA). The normality of data was assessed with the
D’Agostino and Pearson omnibus normality test. Non-
parametric unpaired data were analyzed using the
Mann–Whitney U test or Kruskal–Wallace analysis of
variance (ANOVA), whilst categorical variables were an-
alyzed using the chi-squared test or Fisher’s exact test.
Parametric data were assessed with a Student’s t-test or
one-way ANOVA. Survival data were evaluated by
Kaplan–Meier curves. A P value of less than 0.05 was
considered significant.
Results
Of 128 control subjects in the pre-CPET era, there
were 103 (80.5%) open AAA repairs and 25 (19.5%)
EVARs. Following introduction of CPET, 230 conse-
cutive subjects with elective infra-renal AAA were
studied. Operated cases included open repair in 100
(59.2%) patients and EVAR in 69 (40.8%), representing
a significant increase in the proportion of endovascular
cases (P < 0.001). A further 61 individuals did not have
intervention.
Composition of the CPET-era open surgery, EVAR
and no intervention groups, with respect to CPET out-
comes, are demonstrated in Figure 1.
CPET subgroups
Of the 230 subjects identified in the CPET era, 188
underwent CPET. Tested individuals were stratified by
their anaerobic threshold into three cohorts: CPET-pass
(n = 131, AT ≥ 11.0 ml/kg/min), CPET-fail (n = 35,
AT < 11.0) and CPET-submaximal (n = 22, unable to
generate an AT). Of the patients, 42 were not referred
for CPET (Figure 1).
Table 2 shows demographic data for pre-CPET era
controls and CPET-era subgroups. Control subjects were
of comparable age (median age: 74.0 years, 95% CI: 71.9
to 74.4) and equivalent aneurysm size (median aneurysm
diameter: 6.3 cm, 95% CI: 6.5 to 6.9) to those in the
CPET-stratified subgroups. BMI was infrequently recor-
ded during the pre-CPET era rendering these data un-
suitable for comparison. However, the median age was
significantly higher in the CPET-submaximal group
compared to CPET-pass patients (P < 0.01), the untested
cohort (P < 0.01) and the pre-CPET cohort (P < 0.01). In
addition, BMI was significantly lower in the CPET-pass
cohort than the CPET-fail group (P < 0.05).
Length of inpatient stay
The median length of inpatient stay was significantly
longer for open AAA surgery than EVAR in both the
Figure 1 A consort-type diagram representing the composition of the CPET-era cohort by management type and their subgroups by
CPET stratification. $ and $$ indicate the 42 individuals who were not referred for CPET within this cohort.
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EVAR: 6 days, 95% CI: 4.3 to 8.3 days; P < 0.001) and
post-CPET (open surgery: 10 days, 95% CI: 10.3 to 13.5;
EVAR: 4 days, 95% CI: 4.6 to 6.7 days; P < 0.001)
cohorts.
Open surgery
The length of inpatient stay following open AAA surgery
in the CPET era (median: 10 days, 95% CI: 10.3 to 13.5)
was shorter than that in the pre-CPET era (median: 13
days, 95% CI: 13.9 to 19.0; P < 0.001) principally due to
the reduced duration of stay seen in the CPET-pass sub-
group (Table 3, Figure 2a).Table 2 Demographic data for CPET-era elective infra-renal A
Pre-CPET era
(n = 128)
Elective AAA patients – CPE
CPET-pass (n = 131) CPET
Median 95% CI Median 95% CI Medi
Age (years) 74.0 (**) 71.9 to 74.4 74.0 (**) 72.1 to 74.7 75
BMI (kg/m2) N/A N/A 27.3 (*) 26.8 to 28.2 30.0
Aneurysm size (cm) 6.3 6.5 to 6.9 6.1 6.2 to 6.6 6.1
*P < 0.05, **P < 0.01; significance when compared to the figure highlighted in boldEVAR
The length of inpatient stay following EVAR in the
CPET era (median: 4.0 days, 95% CI: 4.6 to 6.7) was
shorter than that in the pre-CPET era (median: 6.0 days,
95% CI: 5.3 to 8.6; P < 0.05), due to the reduced duration
of stay seen in the CPET-pass subgroup (Table 3,
Figure 2b).
Duration of ITU stay
Open surgery
The length of ITU stay was reduced in the CPET era
compared to pre-CPET controls (CPET era: 3 days,
95% CI: 3.2 to 4.4, pre-CPET: 4 days, 95% CI: 5.5 toAA patients compared to pre-CPET era controls
T performed (n = 188) No CPET (n = 42)
-fail (n = 35) CPET-submaximal (n = 22)
an 95% CI Median 95% CI Median 95% CI
73.1 to 78.3 80.5 76.7 to 81.4 72.5 (**) 70.1 to 74.8
27.6 to 31.4 27.6 25.7 to 31.3 N/A N/A
6.0 to 6.7 6.3 6.0 to 6.9 5.9 5.9 to 6.5
for the given row.
Table 3 Mann–Whitney U comparison of length of stay for open and endovascular AAA repairs
Cohort Median total length of
stay (days) (95% CI)
P value Median length of ITU
stay (days) (95% CI)
P value
Open surgery
Pre-CPET (n = 103) 13 (13.9 to 19.0) 4 (5.5 to 11.2)
CPET era (n = 100) CPET-era open (100/100) 10 (10.3 to 13.5) P < 0.001 3 (3.2 to 4.4) P < 0.01
CPET-pass (74/100) 10 (10.6 to 14.9) P < 0.01 3 (2.9 to 4.3) P < 0.001
CPET-fail (8/100) 11.5 (8.6 to 3.9) P = 0.25 4.95 (2.1 to 8.4) P = 0.88
CPET-submaximal (3/100) 11 (−5.4 to 22.0) P = 0.18 11 (−5.3 to 22.0) P = 0.59
No-CPET (15/100) 8 (6.6 to 11.1) P < 0.001 5 (3.1 to 6.1) P = 0.82
EVARa
Pre-CPET (n = 25) 6 (5.3 to 8.6) N/A N/A
CPET era (n = 69) CPET-era EVAR (69/69) 4 (4.6 to 6.7) P < 0.05 N/A N/A
CPET-pass (29/69) 4 (3.6 to 5.7) P < 0.05 N/A N/A
CPET-fail (7/69) 4 (2.5 to 8.1) P = 0.23 N/A N/A
CPET-submaximal (6/69) 4 (0 to 14.3) P = 0.56 N/A N/A
No-CPET (27/69) 4 (4.4 to 8.8) P = 0.14 N/A N/A
a Insufficient EVAR patients required ITU management for reasonable comparison.
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group (Table 3).
EVAR
Too few EVAR patients required ITU care in the pre-
CPET or CPET-era groups for meaningful statistical
comparison.
Total non-operative inpatient costs
Open surgery
Total non-operative (fully absorbed) costs of inpatient
stay was significantly lower for the CPET-era cohort
(mean: £5,229, 95% CI: 4,452 to 6,006; P < 0.001) com-
pared with pre-CPET controls (mean: £9,637, 95% CI:
7,768 to 11,510). This trend is reflected only by the
CPET-pass subgroup (mean: £5,387, 95% CI: 4,382 to
6,392; P < 0.001) (Figure 3). This is principally due to
the reduced duration of ITU requirement (Table 3) and
median number of end organs requiring support (pre-
CPET: 2 organs, 95% CI 1.9 to 2.4; CPET-pass: 1 organ
95% CI 1.0 to 1.5; P < 0.001) in the CPET-pass
subgroup.
The cost benefit is maintained when calculations are
repeated using influenceable ward costs (pre-CPET:
£8,203 c.f. CPET-era: £4,071; P < 0.001, CPET-pass sub-
group: £4,068; P < 0.001).
EVAR
Non-operative costs are considered a function of total
length of stay due to the minimal requirement for ITU
in both the pre-CPET and CPET-era cohorts (Table 3).Total 30-day mortality
Open surgery
Total 30-day mortality for elective open surgery in the pre-
CPET era was significantly higher than following the intro-
duction of CPET stratification (pre-CPET 30-day mortality:
12.6%, post-CPET 30-day mortality: 4.0%; P < 0.05). These
findings are reflected only by those in the CPET-pass sub-
group (Table 4).
EVAR
No significant difference was demonstrated in 30-day mor-
tality following endovascular repair between the pre-CPET
and CPET-era cohorts (pre-CPET 30-day mortality: 0%,
CPET-era 30-day mortality: 1.4%; P = 1.00).
Survival
Kaplan–Meier survival analysis demonstrated reduced
mid-term survival (from surgery, or from CPET for con-
servatively managed patients, to censorship at closure of
the study) for pre-CPET EVAR and open AAA repair
patients (logrank test: P < 0.05; Figure 4a) compared to
the respective operated cohorts following CPET stratifi-
cation. Median survival for pre-CPET era open AAA re-
pairs was 2,640 days (7.23 years); however, median
survival of the other subgroups could not be calculated
for the period studied. The mortality-rate trends were
confirmed by linear regression and remained significant
(P < 0.001).
Survival analysis comparison between pre-CPET EVAR
patients and CPET-stratified conservatively managed in-
dividuals showed no significant difference (Figure 4b) at
45 months (logrank test: P = 0.96).
Figure 2 Length of inpatient stay. (a) Mann–Whitney U analysis
of total (median) length of inpatient stay for open AAA patients in
the pre- and post-CPET eras. The four bars on the right represent
CPET-stratification outcomes. **P < 0.01; ***P < 0.001. (b) Mann–Whitney
U analysis of total (median) length of inpatient stay for EVAR patients in
the pre- and post-CPET eras. The four bars on the right represent
CPET-stratification outcomes. *P < 0.05; **P < 0.01. CPET:
cardiopulmonary exercise testing; EVAR: endovascular aneurysm
repair; NS: not significant.
Figure 3 One-way ANOVA of total cost of inpatient stay for
open AAA repairs in the pre-CPET and CPET eras. The four bars
on the right represent the CPET-outcome breakdown for patients
from November 2007 to the present. AAA: abdominal aortic
aneurysm; ANOVA: analysis of variance; CPET: cardiopulmonary
exercise testing; NS: not significant (in comparison to the median
value for the pre-CPET cohort); ***: P < 0.001 (in comparison to the
pre-CPET cohort).
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CPET open AAA repair patients and CPET-stratified
conservatively managed individuals did not show signifi-
cance (Figure 4c) at 45 months (logrank test: P = 0.62).
Non-operated patients (CPET era)
Of the 230 patients identified with elective infra-renal
AAA following the introduction of CPET at UHCW
NHS Trust, 61 (26.5%) had not undergone surgery prior
to closure of the study. Within this group, 19 subjects
were pending open or endovascular intervention (that is,
on the waiting list) and 42 (18.3%) were managed con-
servatively. Conservative management was principally inrespect of failed or submaximal CPET, reflected by the
significantly lower mean AT for this cohort (Figure 5a)
despite the normal distribution of AT for the entire 2007
to 2011 cohort (Figure 5b). However, in some cases, alter-
nate non-cardiorespiratory co-morbidities (e.g. ongoing
malignancy), poor quality of life or loss of independence
were quoted as indications for non-operative treatment.
Two individuals chose to be managed conservatively des-
pite an adequate AT for open intervention (Figure 1).
Conservatively managed individuals from the CPET era
exhibited comparable all-cause mortality (28.6%) to the
unstratified pre-CPET control group (41.4%; P = 0.15).
However, all-cause mortality for operated patients in the
CPET era was significantly lower than those treated con-
servatively. These findings hold true for open and
endovascular repair and were reflected only in CPET-pass
patients on subgroup analysis (Table 5). A summary of all-
cause mortality for conservatively managed patients is
shown in Table 6. This reduction in all-cause mortality
translates into a significant survival advantage for CPET-
stratified operated patients compared to conservatively
managed individuals over the studied period (Figure 6;
logrank test (curve comparison): P < 0.05).
Discussion
Since the advent of CPET stratification for elective AAA
patients at UHCW, a significant reduction in 30-day
perioperative mortality rate (4%; Table 4) for all open
repairs (n = 100) has been noted. Individuals achieving
AT ≥ 11 ml/kg/min upon CPET who subsequently
underwent open AAA repair (n = 74/100 open repairs)
exhibited 2.7% perioperative mortality, exceeding the
Table 4 Fisher’s exact test comparison of total 30-day mortality
Cohort 30-day mortality (%) Odds ratio (95% CI) P value
Open surgery
Pre-CPET (Jan 03 to Oct 07) Pre-CPET (n = 103) 12.6
CPET era (Nov 07 to Jul 11) CPET era (total) (n = 100) 4.0 0.29 (0.09 to 0.92) P < 0.05
CPET-pass (74/100) 2.7 0.19 (0.04 to 0.88) P < 0.05
CPET-fail (8/100) 12.5 0.989 (0.11 to 8.70) P = 1.00
CPET-submaximal (3/100) 33.3 2.31 (0.22 to 23.90) P = 0.43
No-CPET (15/100) 0 0.18 (0.01 to 3.20) P = 0.21
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statistically significant reduction when compared to pre-
CPET controls. By comparison, patients with AT < 11
who proceeded nonetheless to open repair (n = 8/100) ex-
perienced equivalent 30-day mortality (12.5%; P = 1.00) to
the unstratified pre-CPET cohort. Individuals undergoing
open AAA repair despite being unable to generate AT
during CPET (n = 3/100) witnessed 33.3% perioperative
mortality (P = 0.43 when compared to the pre-CPET era
cohort). No perioperative deaths were reported following
open AAA repair among the 15 individuals who were sub-
mitted for surgery without CPET; however this did not
achieve statistical significance (P = 0.21) when compared
to pre-CPET era controls.
A pre-operative AT ≥ 11 ml/kg/min was also associated
with reduced total LOS following open repair (P < 0.01)
and EVAR (P < 0.05). Of interest, the 15 individuals sub-
mitted for open surgery without CPET also demonstrated
a significant reduction in total LOS (P < 0.001) when com-
pared to pre-CPETcontrols. Conversely, the 27 individuals
who underwent EVAR without CPET risk stratification
did not show such a reduction in LOS (P = 0.14).
Following open surgery, the CPET-pass subgroup also
benefited from reduced ITU LOS (P < 0.001) and me-
dian number of end organs supported (P < 0.001), which
were not observed among individuals with AT < 11, no
AT, or those who were not referred for CPET.
The reduction in length of inpatient stay demonstrated
for both open and endovascular AAA repair may have
considerable beneficial financial implications for trusts
offering pre-operative CPET stratification.
EVAR patients exhibited a reduction in median length of
stay from 6 to 4 days following the introduction of testing;
hence there was a proportionate reduction in non-
operative costs attributable to fewer bed-nights on general
surgical wards. Confounding factors in this analysis include
a shift from pre-discharge (inpatient) computed tomog-
raphy assessment of stent-graft position prior to 2007, to
30-day surveillance as an outpatient in more recent times.
This may contribute to the reduction in inpatient stay
witnessed within this cohort, although of note, the reduc-
tion in bed-nights required was only significant forindividuals with AT ≥ 11 on subgroup analysis. EVAR was
associated with significantly shorter durations of inpatient
stay, an almost abolished requirement for critical care ser-
vices and lower mortality than open surgery, consistent
with established work [30,36,37]. Thus, the witnessed in-
crease in the proportion of EVAR cases should intuitively
reduce overall elective AAA costs. However, the high cost
of technologically advanced endovascular stents for such
cases effectively abrogates this benefit when compared to
open AAA repairs for individuals of adequate cardiorespi-
ratory fitness [30,38].
A marked financial benefit was seen in open AAA re-
pairs. Non-operative (fully absorbed) inpatient costs for
the CPET-pass subgroup were approximately half of
those for the pre-CPET era; there was an average saving
of over £4,000 per patient. The most influential factors
in this calculation included the significant reduction in
ITU bed-nights utilized by AT ≥ 11 patients in addition
to a lower (median) number of end organs requiring
support, thereby reducing the nightly critical care tariff.
Thus, pre-operative CPET risk stratification appears to
be a financially advantageous method for improving
perioperative outcomes in elective aortic surgery. The
non-operative cost savings in open AAA surgery alone
may allow generation of revenue from such testing in
the longer term. An efficient CPET service should be
readily achievable within the modern vascular unit; this
technology having been successfully transported, assem-
bled and utilized in a field laboratory on the South Col
of Mt. Everest [39], 8,000 m above sea level.
All-cause mortality for the CPET-era cohort (2007 to
2011) was shown to be greater among individuals man-
aged conservatively (28.6%; Tables 5 and 6) following
CPET risk stratification, when compared to individuals
concurrently submitted for open or endovascular surgery
(6.5%; P < 0.001). A significant survival advantage was
confirmed for surgically managed patients compared with
those treated conservatively (for the period studied)
according to Kaplan–Meier analysis (Figure 6). Individuals
within this subgroup were shown to have poorer cardiore-
spiratory fitness than those within the operative subgroups
(Figure 5a, mean AT 9.2 ml/kg/min c.f. 13.3 ml/kg/min;
Figure 4 Kaplan–Meier survival analysis (all-cause mortality).
(a) Comparison of open AAA repair and EVAR in the pre-CPET and
CPET eras. (b) Comparison of pre-CPET EVAR subjects compared
with CPET-era patients managed conservatively. Curve comparison
by the logrank test demonstrated no significant difference (P = 0.96).
Patients on the waiting list for aortic intervention (open or
endovascular) at the close of the study have been removed from
the analysis. (c) Comparison of pre-CPET open AAA repair compared
with CPET-era patients managed conservatively. Curve comparison
by logrank test demonstrated no significant difference (P = 0.62).
Patients on the waiting list for aortic intervention (open or
endovascular) at the closing date of the study have been removed
from the analysis. AAA: abdominal aortic aneurysm; CPET:
cardiopulmonary exercise testing; EVAR: endovascular aneurysm repair;
Rx: management/treatment.
Figure 5 Anaerobic threshold. (a) Mann–Whitney U comparison of
mean (95% CI) for CPET stratified and subsequently operated patients
(13.3 ml/kg/min, 95% CI: 12.5 to 14.2) with those managed conservatively
(9.2 ml/kg/min, 95% CI: 7.2 to 10.9;*** P < 0.001). The dashed line
delineates the evidence-based threshold of 11.0 ml/kg/min. (b)
Anaerobic threshold distributions for all CPET patients (n = 166, normal
distribution on D’Agostino and Pearson omnibus normality test), CPET-
era operated (n = 118, skewed distribution) and CPET conservatively
managed subjects (n = 33, skewed distribution). Submaximal test results
(no AT) have been removed from this analysis. AT: anaerobic threshold;
CPET: cardiopulmonary exercise testing; Rx: management/treatment.
Goodyear et al. Perioperative Medicine 2013, 2:10 Page 9 of 13
http://www.perioperativemedicinejournal.com/content/2/1/10P < 0.001). Data for the conservatively treated subgroup
(Table 6) suggest mortality predominantly resulted from
significant underlying co-morbidities and supports a non-
operative approach, consistent with the findings of previ-
ous studies [40]. Known mortality from ruptured AAA for
the conservatively managed subgroup was 2.4%, within
the limitations of this retrospective study. By implication,
therefore, only a minority of deaths within this subgroup
could have been prevented by intervention (open or en-dovascular AAA repair). However, for an individual of
poor cardiorespiratory status, such an intervention would
have been associated with a high risk of perioperative
complications and mortality [36,40]; that is, death or ser-
ious morbidity may have been hastened by surgery.
Longer-term follow-up would be required, ideally within
the confines of a prospective study, to ascertain the natural
progression of CPET-stratified conservatively managed pa-
tients. Assessment of the frequency of AAA-related and
other deaths, morbidity and survival may develop a clea-
rer evidence base for the optimum management of unfit
individuals.
A remaining equivocation relates to the degree of
stringency with which pre-operative CPET stratification
is applied as a gateway to open surgery. The findings of
this study show that a dramatic reduction in 30-day
mortality (12.6% to 2.7%) is achievable if an AT ≥ 11.0 is
considered an absolute requirement. By contrast CPET-
guided pre-operative decision-making (allowing for clin-
ical discretion) resulted in 4% 30-day mortality and per-
mitted surgical management of a further 26 individuals.
Ultimately, individual vascular units offering this service
Table 5 Fisher’s exact test comparison of all-cause mortality
Cohort Group All-cause deaths P value Odds ratio
CPET era Conservative Rx (n = 42) 12 (28.6%)
Pre-CPET All (n = 128) 53 0.15 N/A
Open (n = 103) 45 0.10 N/A
EVAR (n = 25) 8 0.79 N/A
CPET era All operated (n = 169) 11 (6.5%) <0.001 0.17 (0.07 to 0.43)
All open (n = 100) 8 (8%) <0.01 0.22 (0.08 to 0.58)
CPET-pass OPEN (n = 74) 6 (8.1%) <0.01 0.22 (0.08 to 0.64)
All EVAR (n = 69) 3 (4.3%) <0.001 0.11 (0.03 to 0.43)
CPET-pass EVAR (n = 25) 0 (0%) <0.01 0.05 (0.005 to 0.85 )
CPET: cardiopulmonary exercise testing; EVAR: endovascular aneurysm repair; Rx: management/treatment.
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mortality, or allowing patients of borderline cardiorespi-
ratory fitness the chance of an elective AAA repair. This
controversy, perhaps, warrants high-level debate as we
move towards the 2013 target of 3.5% 30-day mortality,
as set by the VSGBI QIF [31].
Patients undergoing open or endovascular AAA repair
in the pre-CPET era exhibited reduced mid-term sur-
vival when compared to the CPET-era operated cohorts.
Indeed, at 45 months no significant survival advantage
was conferred to the unstratified open surgery or EVAR
patients, when compared to CPET-stratified conserva-
tively managed individuals (Figure 4b,c). For pre-CPET
EVAR patients, who demonstrated negligible periope-
rative mortality rates, a prevalence of significant un-
derlying co-morbidities in subjects selected for this
intervention may contribute to these data, consistent
with the findings of Goodney et al. [41]. The less meta-
bolically demanding EVAR is routinely offered to care-
fully selected patients who fail to achieve a satisfactory
AT on exercise testing. Equivalent survival between
these patients and conservatively managed individuals,
again, suggests a requirement for further study; conser-
vative management may be more appropriate for suchTable 6 A summary of all-cause mortality in non-
operated patients following CPET stratification















AAA: abdominal aortic aneurysm; CPET: cardiopulmonary exercise testing.patients [40], based upon specific morbidities, quality-of
-life outcomes and mode of death.
For pre-CPET-era open AAA repairs, the finding of
equivalent survival at 45 months (Figure 4c) when com-
pared to CPET-stratified individuals rejected for surgery,
strongly reflects the perioperative death rate. This is sug-
gested by the significantly reduced perioperative morta-
lity rates for CPET-stratified open AAA patients and the
concurrent mid-term survival advantage seen for this co-
hort (Figure 4a). Moreover, the improved survival trend
for CPET-stratified open AAA patients suggests that
their superior cardiorespiratory fitness (Figure 5a) may
preserve the survival advantage in the longer term and
should be subject to further study.
Limitations of the study
Compliance with the trust-wide guideline of pre-operative
CPET for all elective AAA patients was incomplete, with
42 (18.3%) patients submitted for surgery (15 open repairs
and 27 EVAR) without testing. Moreover, an element
of cross-over was permitted following risk stratification;Figure 6 Kaplan–Meier survival analysis (all-cause mortality) for
conservatively managed patients in the CPET era in comparison
to those who underwent open or endovascular surgery. *P < 0.05;
curve comparison. CPET: cardiopulmonary exercise testing;
Rx: management/treatment.
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submaximal (no AT) subgroups were not prevented from
proceeding to open surgery upon request. A number of
patients were disinclined to manage their AAA expectantly
(when consideration was given to the accepted 90% mor-
tality following rupture [32]), instead they accepted the in-
creased risk of perioperative mortality and proceeded to
intervention. Morally, this was a difficult view to oppose.
Such limitations of this retrospective study dictated a need
for subgroup analysis of the open repair and EVAR patient
groups within the CPET-era cohort (see Figure 1) to avoid
confounding results.
Furthermore, despite exhaustive efforts to identify all
patients with elective infra-renal AAA within both co-
horts, no conservatively managed individuals could be
detected in the pre-CPET era. Notwithstanding the trust’s
all-comers policy to aneurysm repair prior to 2007, the au-
thors are reluctant to accept that there were no such pa-
tients. By implication, a degree of misclassification and
data loss has to be assumed (leading to information bias).
Such bias is compensated in part, by the subgroup ana-
lyses performed. However, potentially valuable compari-
sons between subjectively determined conservatively
managed individuals of the pre-CPET era and those ob-
jectively identified by CPET, were not possible.
Conclusion
The introduction of pre-operative CPET risk stratifica-
tion for elective AAA repair patients (as a quality im-
provement strategy) has shown improved perioperative
outcomes.
In this retrospective study, an anaerobic threshold
of ≥ 11.0 ml/kg/min has been positively associated with
reduced perioperative (30-day) mortality, total LOS,
length of ITU stay and support requirements for open sur-
gical patients. As a consequence, non-operative costs were
significantly reduced for these individuals. For EVAR pa-
tients, AT ≥ 11.0 was similarly associated with a reduced
total LOS and thus, non-operative costs.
A significant mid-term survival advantage is also seen
for CPET-stratified open repair and EVAR cohorts over
controls, consistent with previous findings [26]. A conse-
quence of CPET stratification (and clinical discretion)
was the generation of a conservatively managed, unfit
patient cohort. These individuals demonstrated greater
all-cause mortality than surgically managed patients,
principally of non-aneurysmal etiology, justifying the
non-operative approach.
Recommendations for further study
A prospective randomized controlled trial (RCT) would
be scientifically most appropriate to confirm the findings
of this study, potentially implicating CPET as an appro-
priate risk assessment tool contributing to mortality pre-diction in AAA surgery, as per NICE recommendations
for further research [42]. A recently published study sug-
gests that the paucity of robust data should preclude
routine adoption of CPET in risk-stratifying patients
undergoing major vascular surgery [15]. However, to the
authors’ knowledge, this manuscript describes the largest
current single-center UK series of patients risk-stratified
in this manner for elective AAA repair, with numerous
potentially advantageous outcomes. Thus, there is prece-
dent for a RCT to clarify this ongoing and controversial
issue.
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